Edition:
United States

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

11.57USD
22 Jun 2018
Change (% chg)

$-0.82 (-6.62%)
Prev Close
$12.39
Open
$12.49
Day's High
$12.50
Day's Low
$11.46
Volume
1,068,311
Avg. Vol
84,277
52-wk High
$20.73
52-wk Low
$5.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.914
FY 2017 Dec '17 0.00 -0.605
Sep '17 0.00 -0.635
Jun '17 0.00 -0.638
Mar '17 0.00 -0.602
FY 2016 Dec '16 0.00 -0.712
Sep '16 0.00 -0.671
Jun '16 0.00 -0.703
Mar '16 0.01 -0.485
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.43
Year Ending Dec-19 5 0.00 0.00 0.00 3.10
Earnings (per share)
Quarter Ending Jun-18 6 -0.77 -0.69 -0.96 -0.69
Quarter Ending Sep-18 6 -0.76 -0.59 -0.96 -0.72
Year Ending Dec-18 6 -3.14 -2.78 -3.57 -2.73
Year Ending Dec-19 5 -3.01 -2.36 -4.34 -2.69
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 248.83 34.14
P/E High - Last 5 Yrs. -- 293.42 47.76
P/E Low - Last 5 Yrs. -- 100.49 25.04
Beta -- 0.74 0.78
Price to Sales (TTM) -- 246.52 8.17
Price to Book (MRQ) 3.12 23.99 4.30
Price to Tangible Book (MRQ) 3.12 30.50 6.00
Price to Cash Flow (TTM) -- 145.85 22.70
% Owned Institutions 23.00 11.95 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.70
Dividend Yield - 5 Year Avg -- 0.20 1.43
Dividend 5 Year Growth Rate -- 2.19 -6.26
Payout Ratio(TTM) -- 41.90 42.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 27.24 5.16
Sales (TTM) vs TTM 1 Yr. Ago -- 139.74 13.40
Sales - 5 Yr. Growth Rate -- 31.45 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago -51.91 -84.38 39.68
EPS (TTM) vs TTM 1 Yr. Ago -3.82 -- --
EPS - 5 Yr. Growth Rate -- 49.40 8.05
Capital Spending - 5 Yr. Growth Rate 80.51 37.00 7.35

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.55
Current Ratio (MRQ) 6.51 6.39 3.63
LT Debt to Equity (MRQ) 0.00 22.27 13.12
Total Debt to Equity (MRQ) 0.00 26.58 17.55
Interest Coverage (TTM) -- -141.36 36.62

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.61 55.11
Gross Margin - 5 Yr. Avg. -- 55.12 52.97
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -3,656.36 -170.99 15.68
Operating Margin (TTM) -- -889.67 -0.25
Operating Margin - 5 Yr. Avg. -3,669.70 -184.49 10.87
Pre-Tax Margin (TTM) -- -784.00 1.68
Pre-Tax Margin - 5 Yr. Avg. -3,640.02 -188.52 11.03
Net Profit Margin (TTM) -- -777.70 -1.61
Net Profit Margin - 5 Yr. Avg. -3,640.02 -187.13 7.38
Effective Tax Rate (TTM) -- 15.50 29.97
Effective Tax Rate - 5 Yr. Avg. -- 19.39 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,135,587 727,159,976
Net Income/Employee (TTM) -1,684,528 -51,964 84,694,665
Receivable Turnover (TTM) -- 18.41 6.01
Inventory Turnover (TTM) -- 2.85 3.67
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.26 -3.55 10.32
Return on Assets - 5 Yr. Avg. -57.83 -0.74 10.99
Return on Investment (TTM) -57.57 -5.25 13.10
Return on Investment - 5 Yr. Avg. -68.25 2.09 14.28
Return on Equity (TTM) -57.86 -6.83 15.09
Return on Equity - 5 Yr. Avg. -87.07 -2.95 15.63
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 3.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Zynerba Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 14.10 12.71 99 80
13 Week 30.73 22.83 99 35
26 Week -4.06 -6.55 90 87
52 Week -35.83 -43.29 55 86
YTD -7.59 -10.31 84 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.21%
# of Holders: 86
Total Shares Held: 3,147,542
3 Mo. Net Change: -1,115,999
# New Positions: 11
# Closed Positions: 16
# Increased Positions: 33
# Reduced Positions: 40
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.